William Dull
Chief Operating Officer
MedTech, Pharma, & Biotech
William (Bill) has over 30 years of senior level executive leadership and operational management expertise from large biotech to start-up and early-stage companies. Bill's most recent BiotechExec assignment was as CEO of InnoMed One, which is developing and commercializing novel medical devices for the infertility space. Prior to InnoMed, he was a founding member and Chief Commercial Officer at Renovia, a privately held MedTech company in women's health.
As an accomplished entrepreneur, manager and investor, Bill has built and led high-performing integrated teams ranging from early-stage research and development, finance, manufacturing, program management, regulatory and successful domestic and global commercial teams with a proven track record of dozens of successful product launches and business development transactions. In addition to serving as partner and COO at BiotechExec, Bill is a member of our growing Ignite network and Senior Executive Advisory Team.
Bill enjoys leading fast-paced, high-growth, scalable businesses with innovative and disruptive technologies that are patient centric.
William holds a Bachelor of Science degree in Business Administration from Georgia State University. He also is an investor and serves as a Board Advisor to several companies.
Career Accomplishments
- •+30 years of start up and early-stage healthcare experience in both public and private life science companies
- •Multiple product launches (US & Global) and go-to-market strategy development and execution for both reimbursable and private-pay products – built scalable commercial models leading to a new standard of care and revenue maximization
- •Raised $100+MM through VC, PE, Angel and debt financing while leading full P&L responsibilities including capital efficiencies of cash flow, balance sheet, OPEX and resource allocation
- •Multiple years leading Business Development/Corporate Strategy and negotiating profitable strategic partnerships ranging from products, service & distribution/licencing agreements, intellectual property, and manufacturing contracts
- •Investor and Board Advisor to several companies
- •Results driven, analytical with a collaborative and inclusive management style
- •Held executive positions at Renovia, Aegerion, Cytovance, Johnson & Johnson, Transkaryotic Therapies and Genentech.